289 related articles for article (PubMed ID: 21226923)
1. Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital.
Schoevaerdts D; Bogaerts P; Grimmelprez A; de Saint-Hubert M; Delaere B; Jamart J; Swine C; Glupczynski Y
BMC Infect Dis; 2011 Jan; 11():12. PubMed ID: 21226923
[TBL] [Abstract][Full Text] [Related]
2. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
[TBL] [Abstract][Full Text] [Related]
3. Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.
Conen A; Frei R; Adler H; Dangel M; Fux CA; Widmer AF
PLoS One; 2015; 10(3):e0120688. PubMed ID: 25803720
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
[TBL] [Abstract][Full Text] [Related]
5. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
Raja NS
J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization.
Friedmann R; Raveh D; Zartzer E; Rudensky B; Broide E; Attias D; Yinnon AM
Infect Control Hosp Epidemiol; 2009 Jun; 30(6):534-42. PubMed ID: 19419270
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia.
Zeynudin A; Pritsch M; Schubert S; Messerer M; Liegl G; Hoelscher M; Belachew T; Wieser A
BMC Infect Dis; 2018 Oct; 18(1):524. PubMed ID: 30342476
[TBL] [Abstract][Full Text] [Related]
8. High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia.
Desta K; Woldeamanuel Y; Azazh A; Mohammod H; Desalegn D; Shimelis D; Gulilat D; Lamisso B; Makonnen E; Worku A; Mannerqvist K; Struwe J; Aspevall O; Aklillu E
PLoS One; 2016; 11(8):e0161685. PubMed ID: 27574974
[TBL] [Abstract][Full Text] [Related]
9. Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram.
García-Tello A; Gimbernat H; Redondo C; Meilán E; Arana DM; Cacho J; Dorado JF; Angulo JC
Scand J Urol; 2018 Feb; 52(1):70-75. PubMed ID: 28893132
[TBL] [Abstract][Full Text] [Related]
10. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
Lagree M; Bontemps S; Dessein R; Angoulvant F; Madhi F; Martinot A; Cohen R; Dubos F;
Med Mal Infect; 2018 May; 48(3):193-201. PubMed ID: 29449049
[TBL] [Abstract][Full Text] [Related]
11. Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia.
Abera B; Kibret M; Mulu W
PLoS One; 2016; 11(11):e0166519. PubMed ID: 27846254
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population.
Eltai NO; Al Thani AA; Al-Ansari K; Deshmukh AS; Wehedy E; Al-Hadidi SH; Yassine HM
Antimicrob Resist Infect Control; 2018; 7():90. PubMed ID: 30069306
[TBL] [Abstract][Full Text] [Related]
13. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
[TBL] [Abstract][Full Text] [Related]
14. Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals.
Lonchel CM; Melin P; Gangoué-Piéboji J; Assoumou MC; Boreux R; De Mol P
Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):79-87. PubMed ID: 22886058
[TBL] [Abstract][Full Text] [Related]
15. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain.
Valverde A; Coque TM; Sánchez-Moreno MP; Rollán A; Baquero F; Cantón R
J Clin Microbiol; 2004 Oct; 42(10):4769-75. PubMed ID: 15472339
[TBL] [Abstract][Full Text] [Related]
16. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
Aris P; Boroumand MA; Rahbar M; Douraghi M
Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
[TBL] [Abstract][Full Text] [Related]
17. Emerging Perils of Extended Spectrum
Parajuli NP; Maharjan P; Joshi G; Khanal PR
Biomed Res Int; 2016; 2016():1782835. PubMed ID: 28119921
[No Abstract] [Full Text] [Related]
18. Frequency of extended spectrum beta lactamase producing enterobacteriaceae among urinary pathogen isolates.
Afridi FI; Farooqi BJ; Hussain A
J Coll Physicians Surg Pak; 2011 Dec; 21(12):741-4. PubMed ID: 22166694
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe.
Bogaerts P; Huang TD; Bouchahrouf W; Bauraing C; Berhin C; El Garch F; Glupczynski Y;
Microb Drug Resist; 2015 Dec; 21(6):643-50. PubMed ID: 26098354
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Carriage in Patients Admitted to Intensive Care Unit in a Tertiary Care Hospital in Thailand.
Kiddee A; Assawatheptawee K; Na-Udom A; Boonsawang P; Treebupachatsakul P; Walsh TR; Niumsup PR
Microb Drug Resist; 2019 Oct; 25(8):1182-1190. PubMed ID: 31140920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
